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Abstract
We aimed to investigate the use of placebos (e.g. saline injections) and non-specific treatments (e.g. vitamin supplements in
individuals without a relevant deficiency) among physicians working in private practices in Germany, and how such use is
associated with the belief in and the use of complementary and alternative treatments, and basic professional attitudes. A
four-page questionnaire was sent to nationwide random samples of general practitioners (GP), internists and orthopaedists
working in private practices. The response rate was 46% (935 of 2018). 24% of GPs, 44% of internists and 57% of
orthopaedists had neither used pure placebos nor non-specific therapies in the previous 12 months. 11% percent of GPs,
12% of internists and 7% of orthopaedists had exclusively used pure placebos; 30%, 33% and 26%, respectively, had
exclusively used non-specific therapies; 35%, 12% and 9% had used both. Age, sex and agreement to the statement that
physicians should harness placebo effects were not significantly associated with any pattern of use. Exclusive use of pure
placebos was associated with being a GP, being an internist, and having unorthodox professional views. In addition to these
three factors, a lower use of CAM therapies and a wish for having more time was associated with the exclusive use of non-
specific therapies. Among physicians using both pure placebo and non-specific therapies, heterodox views were also
somewhat more pronounced. However, associations were particularly strong for being a GP (Odds ratio 11.6 (95%CI 6.41;
21.3)) and having orthodox views (Odds ratio 0.10 (95%CI 0.06; 0.18)) among this group. In conclusion, the use of placebos
and non-specific treatments varies strongly between medical specialties and is associated with basic professional attitudes.
The findings support the view that the use of placebos and, in particular, of non-specific therapies is primarily a coping
behaviour for difficult and uncertain situations.
Citation: Linde K, Friedrichs C, Alscher A, Wagenpfeil S, Meissner K, et al. (2014) The Use of Placebo and Non-Specific Therapies and Their Relation to Basic
Professional Attitudes and the Use of Complementary Therapies among German Physicians – A Cross-Sectional Survey. PLoS ONE 9(4): e92938. doi:10.1371/
journal.pone.0092938
Editor: Laxmaiah Manchikanti, University of Louisville, United States of America
Received February 18, 2014; Accepted February 26, 2014; Published April 2, 2014
Copyright:  2014 Linde et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: There was no external funding for the study. Costs were covered from the regular budget of the Institute of General Practice, Technische Universität
München. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Klaus.Linde@tum.de
Introduction
There is clear evidence that many physicians in primary and
secondary care, to some extent, use treatments for patients or in
situations even though they hold a personal view that these
treatments only have non-specific or placebo effects. This evidence
mainly comes from two quite different lines of research. The first
line consists of quantitative surveys on the use of placebos outside
of clinical trials [1–4]. For example, a recent survey among UK
GPs found that 12% had used treatments that do not contain any
active components such as saline injections or sugar pills (called
placebos or ‘pure’ placebos) at least once in their professional life.
97% had used treatments containing active or potentially active
components that did not have a specific effect on the condition
treated, such as antibiotics for viral infections or vitamin
supplements in individuals without relevant deficiency (called
‘impure’ placebos or non-specific treatments) [4]. While other
motivations are also usually examined, an implicit assumption in
most of these surveys is that eliciting placebo effects is a major
reason for providing such treatments. For example, one major
survey defined placebo treatment to participants as ‘‘a treatment
whose benefits derive from positive patients expectations’’ [3].
The second line of research is mostly qualitative research on
difficult or inappropriate prescribing decisions (e.g. [5–9]). While
the word placebo rarely ever shows up, these studies deal with the
motivations for using interventions that, in placebo surveys, are
considered typical examples of non-specific treatments or ‘impure’
placebos (e.g. antibiotics for viral infections). The findings of this
research suggest that uncertainty, perceived patients’ expectations
and pressure to act are the main reasons to use such treatments.
During their training, physicians internalize a professional ideal
that any treatment should have specific activity and should be
administered or prescribed only when necessary [5]. However, this
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ideal conflicts with experiences in everyday practice where
physicians face considerable uncertainty. From this perspective,
the use of non-specific treatments could be seen as a problem-
solving tool that can be used to manage a variety of difficult
situations in routine practice [9].
Interpreting the use of non-specific treatments (and to some
extent also of placebos) as a somewhat ambiguous strategy to deal
with difficult and uncertain situations is in line with empirical
findings. In placebo surveys, many physicians report patient
expectations and avoiding conflicts as motivations for using
placebos and non-specific treatments in addition to eliciting
placebo effects [1–4,10]. In ambulatory care, non-specific treat-
ments are used much more often than pure placebos [1–4].
Applying a placebo implies a very conscious decision and, in most
cases, giving deceptive information. Applying non-specific treat-
ments is usually a less challenging option. There is also some data
suggesting that the use of non-specific treatments is particularly
widespread among GPs [1,2,4,10,11]. GPs see many patients for
whom it is difficult to make a clear diagnosis [12] and who have
minor ailments [13]. Non-specific treatments should be a less
relevant option for specialists, who mainly see pre-selected cases
with more advanced disease often receiving multiple treatments.
One could also expect an association between the use of
complementary and alternative medicine (CAM) and the use of
non-specific treatments [14]. To those who believe in a given
CAM modality, it offers - or seems to offer - ‘specific’ diagnostic
and therapeutic solutions for patients for whom conventional
medicine does not provide satisfactory solutions. As a result,
convinced CAM users might report less use of treatments they
consider non-specific. Finally, one would expect that basic
professional attitudes have a relevant role on the behaviour of
physicians. For example, a physician firmly believing that
medicine has to be based on sound science could be less likely
to use placebos, non-specific treatments and CAM treatments.
In the survey presented in this paper we aimed to investigate the
use of placebos and non-specific treatments among GPs, internists
and orthopaedists working in private practice in Germany. We
also asked for beliefs in and the use of major CAM modalities and
basic professional attitudes to investigate how these issues are
related to the use of placebos and non-specific treatments.
Methods
Design
The study was a postal, cross-sectional survey. It was approved
by the ethical review board of the Medical Faculty of the
Technische Universität München. We randomly (using the
random sampling function in SPSS) selected 700 GPs, 700
internists and 700 orthopaedists working in private practice from
a commercially available database (www.adressendiscount.de) with
the addresses and accredited specializations of more than 90% of
all physicians providing ambulatory care in Germany. In late
October 2012 selected physicians received a letter with informa-
tion on the study, a four-page questionnaire and a pre-stamped
envelope. Non-responders received up to two reminders until early
December 2012. Data was entered into an SPSS database which
was closed on February 28, 2013.
Questionnaire
The rationale, the development and the details of the
questionnaire have been reported elsewhere [14]. Briefly, the
questionnaire consisted of 50 items divided into five blocks. Block
A consisted of four questions on the use of placebos (use, frequency
of use in the last 12 months, repeated use in single patients and
availability of placebo preparations in the practice) and block B of
three questions on the use of non-specific treatment (use,
frequency of use in the last 12 months and types of interventions
used). We used the term ‘‘non-specific treatment’’ because
cognitive interviews during the development have shown that
physicians had difficulties with the term ‘‘impure placebo’’ [14].
Block C included 21 questions on the belief in the specific effects
and on the use of seven complementary therapies (acupuncture,
homeopathy, chirotherapy, osteopathy, herbal medicine, other
classical naturopathic treatments, vitamins/microelements (further
treatments could be added)), and on the qualifications for these
therapies. Block D consisted of 13 statements on basic professional
attitudes. Physicians were asked to indicate the level of agreement
on a four-point scale. Based on theoretical considerations [5,14]
and exploratory factor analysis, answers to 12 statements were
summarized on three scales: orthodox views (five statements
expressing conventional medico-scientific views, e.g. ‘‘whenever
possible only evidence-based treatments should be used’’);
heterodox views (three statements related to the limitations of
conventional medicine and usefulness of CAM, e.g. ‘‘in my daily
practice I am confronted with many patients in which the classical
knowledge from textbooks is insufficient’’), and time/patient-
doctor relationship (four items addressing the need of time and the
relevance of the patient-doctor relationship). We also analyzed the
statement on harnessing placebo effects (‘‘as a physician one
should intensively harness positive psychological effects (e.g. ‘drug
physician’)’’) separately because it was a central consideration. In
block E socio-demographic and practice characteristics were
documented.
Statistics
All analyses were performed using IBM SPSS Statistics 21 using
all available data. Data were analyzed descriptively for the three
physician groups using absolute counts, percentages, means and
standard deviations, medians and quartiles, as appropriate. 95%
confidence intervals (95% CI) for frequencies were estimated using
the bootstrapping function in SPSS. P-values for comparisons
between the three specialties were calculated using Chi2-tests, a
Kruskal-Wallis test, and analysis of variance. To investigate which
physician characteristics were associated with the exclusive use of
placebos, the exclusive use of non-specific therapies and the use of
both placebos and non-specific therapies we performed multivar-
iate multinomial regression (using neither use as reference
category). Independent variables for the final model were age,
sex, specialty (using orthopaedists as reference group), the four
scales regarding basic professional attitudes, CAM use and CAM
belief. Assuming a response rate of about 40%, we sent out 700
questionnaires to have 80% power to detect a 12% difference in
the use of non-specific treatments between GPs (assumed
prevalence 60%) and internists (48%) using a two-tailed p-value
of 0.05 (n per group 288 patients, calculation with G*Power 3.1.2
for Fisher’s exact test).
Results
Of the 2100 questionnaires sent out, 72 could not be delivered
(address no longer valid). Furthermore, six physicians were
actually working in a hospital, three had retired and one had
died. So our final sample consisted of 2018 physicians (685 GPs,
661 internists and 669 orthopaedists). 935 (46%; 319 GPs, 311
internists and 305 orthopaedists) sent back a completed question-
naire until the closing of the database. 41% of GPs, 20% of
internists and 10% of orthopaedists were women (p-value for
differences between specialties ,0.001) and the mean age was 55
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years among GPs, 53 among internists and 54 among orthopae-
dists (p = 0.19).
The use of placebos in the previous 12 months was reported
more frequently by GPs (46%; 95%CI 40% to 51%) than by
internists (24%; 95%CI 19% to 29%) and orthopaedists (17%;
95%CI 13% to 21%; see Table 1). Among those who had used a
placebo, the median frequency of use was 2 per year (first and
third quartile 1 and 5) with minor differences between specialties.
35 physicians (5%) reported that they had prefabricated placebos
tablets or globules in practice. However, two physicians named
products which actually were supplements.
Non-specific treatments were used in the last 12 months by 65%
(95%CI 60% to 70%) of GPs, 45% (95%CI 39% to 51%) of
internists and 36% (95%CI 30% to 41%) of orthopaedists. The
median frequency of use among users was 20 (first and third
quartile 10 and 50; no statistically significant differences between
groups). Vitamins, herbal remedies, minerals and microelements
and homeopathic remedies were most often used as non-specific
treatments. Antibiotics were used by 34% (95%CI 29% to 39%) of
GPs, 17% (95%CI 13% to 21%) of internists and only 1% (95%CI
0% to 2%) of orthopaedists.
Overall, 24% (95%CI 19% to 29%) of GPs, 44% (95%CI 38%
to 50%) of internists and 57% (95%CI 51% to 62%) of
orthopaedists had neither used pure placebos nor non-specific
therapies in the previous 12 months. 11% (95%CI 8% to 15%) of
GPs, 12% (95%CI 8% to 15%) of internists and 7% (95%CI 5%
to 10%) of orthopaedists reported the exclusive use of pure
placebos. 30% (95%CI 25% to 35%) of GPs, 33% (295%CI 7% to
38%) of internists and 26% (95%CI 21% to 31%) had exclusively
used non-specific therapies. The use of both placebos and non-
specific therapies was reported by 35% (95%CI 30 to 40%) of GPs,
12% (95%CI 9% to 16%) of internists and 9% (95%CI 6% to
13%) of orthopaedists.
On average, internists agreed more with orthodox views and
less with heterodox views than the two other groups (see Table 2).
GPs agreed with heterodox views more than orthopaedists and
Table 1. Use of pure placebos and non-specific therapies among respondents.
GPs (n = 319) Internists (n = 305) Orthopaedists (n = 311)
Use of placebos
Ever use 168 (52%; 43 to 54%) 92 (30%; 25 to 35%) 60 (19%; 15 to24%)
Use in the last 12 months
- never 173 (54%; 49 to 60%) 233 (76%; 72 to 81%) 259 (83%; 79 to 88%)
- 1 to 5 times 111 (35%; 30 to 40%) 55 (18%; 24 to 23%) 30 (10%; 6 to 13%)
- 6 to 20 times 24 (8%; 4 to 10%) 14 (5%; 2 to 7%) 13 (4%; 2 to 7%)
- 21 to 50 times 8 (3%; 1 to 4%) 1 (,1%; 0 to 1%) 3 (1%; 0 to 2%)
- more than 50 times 3 (1%; 0 to 2%) 2 (1%; 0 to 2%) 6 (2%; 1 to 4%)
- Median frequency (first/third quartile) among users 2 (1/5) 2 (1/5) 5 (2/10)
Use in single patients more than once 79 (25%; 20 to 30%) 42 (14%; 10 to 18%)) 28 (9%; 6 to 12%))
Prefabricated placebo in practice 18 (6%; 4 to 9%) 14 (5%; 2 to 7%) 3 (1%; 0 to 2%)
Use of non-specific therapies
Ever use 213 (67%; 62 to 72) 143 (47%; 28 to 38%) 119 (38%; 33 to 44%)
Use in the last 12 months
- never 111 (35%; 30 to 40%) 168 (55%; 50 to 61%) 200 (64%; 59 to 69%)
- 1 to 5 times 37 (12%; 8 to 15%) 26 (9%; 6 to 12%) 22 (7%; 5 to 10%)
- 6 to 20 times 99 (31%; 26 to 36%) 64 (21%; 16 to 26%) 45 (15%; 11 to 19%)
- 21 to 50 times 39 (12%; 9 to 16%) 28 (9%; 6 to 13%) 12 (4%; 2 to 6%)
- more than 50 times 33 (10%; 7 to 14%) 19 (6%; 4 to 9%) 32 (10%; 7 to 14%)
- Median frequency (first/third quartile) among users 15 (10/48) 20 (10/50) 20 (10/100)
Types of treatments used
- vitamins 136 (43%; 38 to 48%) 81 (27%; 22 to 32%) 71 (23%; 18 to 28%)
- herbal remedies 135 (42%; 37 to 47%) 91 (30%; 25 to 35%) 55 (18%; 14 to 22%)
- minerals and micro elements 112 (35%; 30 to 41%) 80 (26%; 21 to 31%) 47 (15%; 11 to 19%)
- homeopathic remedies 106 (33%; 28 to 39%) 47 (15%; 11 to 20%) 62 (20%; 15 to 24%)
- antibiotics 108 (34%; 29 to 39%) 51 (17%; 13 to 21%) 3 (1%; 0 to 2%)
- analgesics 44 (14%; 10 to 18%) 17 (6%; 3 to 8%) 14 (5%; 2 to 7%)
Pattern of use in the last 12 months
- neither 76 (24%; 19 to 29%) 133 (44%; 38 to 50%) 177 (57%; 51 to 62%)
- pure placebos only 35 (11%; 8 to 15%) 35 (12%; 8 to 15%) 23 (7%; 5 to 10%)
- non-specific therapies only 97 (30%; 25 to 35%) 100 (33%; 27 to 38%) 82 (26%; 21 to 31%)
- both 111 (35%; 30 to 40%) 37 (12%; 9 to 16%) 29 (9%; 6 to 13%)
Numbers are absolute frequencies (percentages; 95%-CI) unless otherwise indicated.
doi:10.1371/journal.pone.0092938.t001
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clearly more than internists. GPs also agreed more with statements
on the need of more time and the patient-doctor relationship and
they were more positive about harnessing placebo effects than
internists and orthopaedists, though the differences were relatively
small. GPs and orthopaedists considered CAM treatments to be
specifically active more often than internists but there was strong
variation within all three physician groups. The use of CAM
therapies was particularly frequent among orthopaedists and least
prevalent among internists.
Table 3 summarizes the findings from multivariate multinomial
regression analyses on associations between physician character-
istics and different patterns of use of placebos and non-specific
therapies. In general, age, sex and agreement to the statement that
physicians should harness placebo effects were not significantly
associated with any pattern of use. Exclusive use of pure placebos
was associated with being a GP, an internist, and more
disagreement with orthodox views. In addition to these three
factors, a lower belief in specific effects of CAM therapies and a
higher value on the time and relationship scale were associated
with exclusive use of non-specific therapies. The same five factors
were associated with using both pure placebos and non-specific
therapies, but associations were particularly strong for being a GP
(OR 11.6 (95%CI 6.26; 21.6)) and agreeing with orthodox views
(OR = 0.11 (95%CI 0.06; 0.19)) among this group.
Discussion
Physicians working in private practice in Germany use non-
specific treatments much more frequently than (pure) placebos.
The use of both placebos and non-specific therapies is more
widespread among GPs than among internists and - contrary to
our initial expectations [14] - lowest among orthopaedists.
Professional attitudes and the belief in and the use of CAM
treatments differ markedly within and between medical specialties
with internists being, on average, most sceptical and orthopaedists
using CAM treatments most often. In multivariate regression
analyses, the factors most strongly associated with the use of
placebos and non-specific treatments were being a GP (higher
likelihood of use) and holding orthodox views (lower likelihood).
Stronger belief in specific effects of CAM but not more frequent
use of CAM was associated with a lower use of non-specific
treatments.
Our results confirm previous findings from other countries that
non-specific treatments are used much more frequently than
placebos [1,3,4,10,11,15,16]. Compared to physicians working in
ambulatory care in other countries, the proportion of German
physicians using placebos seems relatively high while the reported
use of non-specific treatments does not seem unusual. While our
prevalence estimates of the use of placebos and non-specific
treatment are of some interest, the clear strengths and novel
aspects of our study are regarding the investigation of differences
between physician specialties and of the influence of professional
attitudes and CAM belief or use. Indirect comparison of different
surveys already suggested that GPs use placebos and non-specific
treatments more often than specialists [1]. But so far only one
Danish survey of 503 physicians directly compared GPs, private
specialists and hospital-based physicians [10]. 86% of general
practitioners had used at least one of such treatments in the last
year compared to 54% of hospital doctors and 41% of private
specialists. Our results show that there are also significant
differences between different types of private specialists. The
differences between GPs and internists were expected and seem
plausible (see introduction), but the findings on orthopaedists
surprised us. To the best of our knowledge, orthopaedists in
private practice have not been included in previous placebo
surveys [1]. We had included this group because it seemed of
considerable interest. Orthopaedists are mainly trained in hospitals
where they typically treat selected patients with surgical proce-
dures. If orthopaedists later provide ambulatory care in private
practice they very often see patients suffering from chronic pain or
functional musculoskeletal disorders for which their training
should have provided only few specific solutions. As we expected,
orthopaedists agreed less than GPs and internists to the statement
that their post-graduate medical training prepared them well for
their work in private practice. Nevertheless, orthopaedists reported
the lowest use of placebos and non-specific treatments and instead
use and believe in CAM modalities – in particular, chirotherapy,
acupuncture and osteopathy (detailed results will be reported
Table 2. Basic professional attitudes, belief in and use of CAM therapies.
GPs Internists Orthopaedists
Basic professional attitudes (1 = strong agreement, 4 = strong
disagreement; n = 897)
Scale orthodox views (5 items) 2.05 (1.99; 2.11) 1.80 (1.75; 1.86) 2.06 (2.01; 2.12)
Scale heterodox views (3 items) 2.37 (2.30; 2.44) 2.89 (2.81; 2.95) 2.56 (2.50; 2.62)
Scale time/patient-doctor relationship (4 items) 1.57 (1.52; 1.63) 1.71 (1.65; 1.77) 1.67 (1.61; 1.73)
Single item harnessing placebo effects 1.85 (1.75; 1.94) 1.96 (1.87; 2.05) 1.98 (1.89; 2.07)
Average CAM belief (1 = only placebo, 5 = specifically active; n = 873)
Summary scale 7 therapies 3.49 (3.41; 3.58) 3.08 (2.99; 3.17) 3.51 (3.44; 3.58)
Number of CAM therapies used more often than once per week
(n = 874)
- none 46 (15%; 11 to 19%)) 148 (52%; 45 to 57%) 11 (4%; 2 to 6%)
- one 51 (17%; 13 to 21%) 80 (28%; 23 to 33%) 31 (11%; 8 to 15%)
- two 82 (27%; 23 to 33%) 28 (10%; 7 to 13%) 93 (33%; 28 to 39%)
- three to four 90 (19%; 24 to 35%)) 26 (9%; 6 to 13%) 95 (34%; 29 to 39%)
- five to seven 35 (11%; 8 to 15%) 5 (2%; 0 to 4%) 50 (18%; 14 to 22%)
Values are means (95%-CI) or absolute frequencies (percentages; 95%CI).
doi:10.1371/journal.pone.0092938.t002
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elsewhere) – much more often than GPs and internists. Our
finding that belief in the efficacy of CAM modalities is associated
with lower reporting of the use of non-specific treatments and no
association with actual CAM use would fit with our assumption
that whether a treatment is considered specific or non-specific
depends on the view of the individual physician. The differences
between specialities regarding basic professional attitudes might be
due to a considerable extent to personal traits already influencing
the choice of work field. However, these differences probably at
least partly also reflect experiences in real world practice.
About a quarter of GPs and about half of internists and
orthopaedists claimed to manage their daily routine without any
use of placebos or non-specific treatments. Furthermore, the
agreement to the statement that ‘‘as a physician one should
intensively harness positive psychological effects (e.g. ‘drug
physician’)’’ did not show a strong association with placebo or
non-specific treatment use. This could indicate that many
physicians think that placebos or non-specific treatments are not
necessarily needed for harnessing placebo effects. This leads to the
central question about whether using placebos and non-specific
treatments is ethically and professionally acceptable [17]. In a
report on placebo use, the American Medical Association Council
on Ethical and Judicial Affairs stated that the use of placebos or
non-specific therapies is not ethically acceptable if it serves ‘‘the
convenience of the physician rather than to promote the well-
being of the patient’’ [18]. Two basic scenarios of ‘‘convenience’’
prescriptions have been distinguished: one where the physician
tries to get the patient to stop complaining without providing
adequate information on the treatment, and a second where the
physicians states that he considers the treatment demanded by the
patient unnecessary but finally prescribes it [19]. While we think
that many convenience prescriptions can and should be avoided,
the simple dichotomy between convenience and benevolent
prescription does not reflect the complexity of the patient-
physician relationship in the real world [9,20]. There are multiple
situations in medical practice in which it is difficult to draw a clear
line of what is an unacceptable behaviour and what justifiable
human care.
When interpreting the findings of our survey, several limitations
have to be kept in mind. Less than half of the physicians contacted
filled in the questionnaire and it is not clear whether the
prevalence estimates found among respondents can be general-
ized. However, a main focus of our survey was the comparison
between medical specialties. Given the very similar response rates
in the three groups it seems unlikely that reasons for selection differ
between the groups. Therefore, the marked differences between
medical specialities are very likely to be a real phenomenon. Due
to the unclear and subjective distinction between specific and non-
specific treatments [1,21], any prevalence estimates on non-
specific treatment use have to be interpreted with great caution.
For example, the CAM treatment considered specific by a believer
might be reported as non-specific treatment by a sceptic. The very
frequent use of non-specific treatments among GPs reported in the
UK [4] might simply reflect that physicians in this country are
more aware of the limited evidence many interventions have. At
the same time, one can speculate that there is under-reporting of
non-specific treatment use due to social desirability. Our
‘‘measurement’’ of basic professional attitudes can be considered
only a first attempt and should not be considered a properly
validated instrument. The cognitive interviews performed during
the development phase made clear that the issues addressed are
very difficult to grasp quantitatively in a standardized question-
naire [14]. Finally, while our analyses were based on pre-specified
assumptions they have to be considered exploratory.
In conclusion, we think that our findings support the view that
the use of placebos and, in particular, of non-specific therapies is a
coping behaviour for difficult and uncertain situations. Further-
more, in many situations the hope to elicit placebo effects is
probably more a justification than a primary motivation to use
such treatment. Qualitative studies are needed to better under-
stand why and in which situations physicians use placebos or non-
specific treatments. Quantitative studies could investigate, for
example, to what extent personality traits, styles of practicing (e.g.
paternalistic vs. cooperative) or strategies to deal with uncertainty
influence such use. A priority for future research should be to
investigate how physicians not using placebos and non-specific
treatment manage difficult situations. Based on the findings of such
research it should be possible to develop educational strategies to
reduce the inappropriate use of placebos and non-specific
treatments. We doubt that it is possible or adequate to completely
eliminate the use of placebos and non-specific treatment from
clinical practice. In this respect, research on how such interven-
tions can be applied in an ethically acceptable manner is clearly
desirable.
Table 3. Factors associated with the pattern of the use of placebos and non-specific treatments in multivariate multinomial
regression (n = 796, r2 = 0.30 (Nagelkerke)).
Only pure placebos OR (95%CI) Only non-specific therapies OR (95%CI) Both OR (95%CI)
Age (per year) 1.00 (0.97; 1.04) 1.00 (0.98; 1.03) 1.01 (0.98; 1.04)
Sex female 1.13 (0.60; 2.11) 1.17 (0.74; 1.87) 0.69 (0.39; 1.22)
GP 3.41 (1.66; 7.04) 3.46 (2.07; 5.76) 11.8 (6.35; 22.1)
Internist 3.41 (1.60; 7.26) 2.47 (1.45; 4.21) 3.57 (1.77; 7.21)
Orthodox views 0.38 (0.20; 0.72) 0.21 (0.13; 0.33) 0.11 (0.07; 0.20)
Heretic views 0.93 (0.55; 1.57) 1.24 (0.85; 1.79) 1.44 (0.92; 2.25)
Time & relationship 1.19 (0.70; 2.01) 2.01 (1.37; 2.95) 2.07 (1.29; 3.33)
Harnessing placebo effects 1.22 (0.88; 1.69) 1.24 (0.98; 1.56) 1.32 (0.98; 1.77)
CAM belief 1.16 (0.73; 1.83) 0.42 (0.30; 0.58) 0.47 (0.32; 0.70)
CAM use 1.15 (0.87; 1.53) 1.12 (0.92; 1.38) 1.14 (0.89; 1.44)
Odds ratios (OR) .1 indicate more frequent use compared to physicians using neither placebos nor non-specific treatments.
doi:10.1371/journal.pone.0092938.t003
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18. Bostick NA, Sade R, Levine MA, Stewart DM, Jr (2008) Placebo use in clinical
practice: report of the American Medical Association Council on Ethical and
Judicial Affairs. J Clin Ethics 19:58–61.
19. Hrobjartsson A (2008) Clinical placebo interventions are unethical, unnecessary,
and unprofessional. J Clin Ethics 19:66–69.
20. Lichtenberg P, Heresco-Levy U, Nitzan U (2004) The ethics of the placebo in
clinical practice. J Med Ethics 30: 551–554.
21. Louhiala P (2012) What do we really know about the deliberate use of placebos
in clinical practice? J Med Ethics 38:403–405.
Use of Placebo and Non-Specific Therapies among German Physicians
PLOS ONE | www.plosone.org 6 April 2014 | Volume 9 | Issue 4 | e92938
